1 / 36

Grand Rounds May 10, 2006

Grand Rounds May 10, 2006. Derek R. Seiler, M.D. George J. Sheplock, M.D. Case Report. 5 yr old male, 19 kg Laparoscopic splenectomy secondary to hereditary spherocytosis Exam unremarkable Healthy except for baseline HCT 27.6

mali
Download Presentation

Grand Rounds May 10, 2006

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Grand RoundsMay 10, 2006 Derek R. Seiler, M.D. George J. Sheplock, M.D.

  2. Case Report • 5 yr old male, 19 kg • Laparoscopic splenectomy secondary to hereditary spherocytosis • Exam unremarkable • Healthy except for baseline HCT 27.6 • Hematologist seen pre-op and stated “no contraindications for surgery” • Vitals signs unremarkable, Temp 36.9 C

  3. OR • Inhalational Induction with nitrous, sevo, oxygen • IV access obtained • Mivacurium 6mg, uneventful tracheal intubation • Fentanyl (5ug/kg in incremental doses), oxygen, vecuronium (0.1mg/kg) and isoflurane • Ventilation with TV 200ml, RR 13 and EtCO2 ranged 31-37 • Esophageal Temp ranged from 36.9-37.6 C

  4. To PACU • Case Summary • 360 ml IV Fluid • Clear urine 60ml, EBL 45ml and surgical time was 74 without complication • After assessment using nerve stimulator: • 1mg neostigmine, 0.2mg glycopyrulate • Awake, moving all 4 limbs, extubated and taking to PACU with O2 via face-mask - no pulse oximeter(departmental policy) by anesthesia resident

  5. Arrival to PACU • Upon arrival – crying, calling for mother, and trying to remove NGT when…. • Suddenly collapsed and became apneic • EKG showed HR <50 • Previously healthy child, What happened?

  6. Later in PACU • PALS Protocol Initiated • Re-intubated without incident • 10 min later femoral arterial line obtained, ABG: • PH 7.237, pCO2 18.4, pO2 429, HCO3 7.6, Na 130, K 9.2, HCT 26 • Temp unchanged, no rigidity • any New thoughts?

  7. Later in PACU • PALS Protocol Initiated • Re-intubated without incident • 10 min later femoral arterial line obtained, ABG: • PH 7.237, pCO2 18.4, pO2 429, HCO3 7.6, Na 130, K 9.2, HCT 26 • Temp unchanged, no rigidity • Following appropriate treatment, K was reduced to 7.0 and after 45 min CPR patient regained NSR. • “Electrolytes and acid-base status normalized over several hours.”

  8. DDX • Respiratory • Common cause of cardiac arrest in children • No Sx of obstruction, stridor, or laryngospasm • Easy to ventilate and intubate • Authors initially thought rx-related or cardiac • Iatrogenic – no K+ solutions available • No cardiac hx and no evidence of electrical imbalance such as prolonged QT/Torsades • VSS & Slight Temp increase intraop • No symptoms of hyperkalemia on intra-op EKG • No succinycholine used

  9. Further Investigation • Pre-operative blood sample was sent for CK and K+. • 15,000 U/l and 5.0 mmol/l respectively • CK rose to 128,789 U/l next day and urine was positive for myoglobin • EEG declared brain death on POD 7 • Muscle bx returned positive for DMD • Additional discussion with parents revealed no history or symptoms

  10. Etiology • Perianesthetic Rhabdomyolysis with Hyperkalemia • Also known as Anesthesia Induced Rhabdomyolysis (AIR) • Mechanism unclear

  11. Not Unique • 6th REPORTED case of hyperkalemic arrest without succinylcholine • Previous 5 reported cases had no h/o DMD, had uneventful intraop course with VA, all developed hyperkalemia and rhabdomyolysis postop in PACU, 3 had cardiac arrest. • Mild Becker’s with K+ reaching 12 mEq/l • One within 10 minutes of induction • Similar case 15 minutes into recovery room • Others previously asymptomatic individuals

  12. Duchenne’s Overview • Muscular dystrophy is a term used to define a group of degenerative genetic diseases progressively affecting skeletal muscles, with no motor neuron abnormality. • Duchenne muscular dystrophy, also called Pseudohypertrophic Muscular Dystrophy, is the most common among muscular dystrophies. • The defect in dystrophinopathies such as DMD, results from lack of membrane stabilizing protein dystrophin. See Figure next slide:

  13. Duchenne’s Overview • Caused by mutations in the short arm of chromosome X, DMD affects mainly boys, who inherit the disease from their mothers (X-linked recessive); women are in general asymptomatic. • Disruption of cell membrane causes influx of Ca+ and eventual muscle cell degeneration. • Incidence is 3 to every 10,000 live births.

  14. Symptoms • This disorder is typically diagnosed after 2 years of age (2-5 yo), when signs and symptoms, such as muscle weakness, start to become evident. • Symptoms start in hips, pelvic region, thighs and shoulders, with pseudodystrophy of several muscle groups, such as calf muscles, because of fatty infiltration. • CK is 30-300x normal, 70% of carriers have increased levels as well. • Diagnostic is confirmed by muscle biopsy.

  15. Prognosis • It is a progressive disease which may end up affecting all skeletal muscles, including respiratory and cardiac muscles. • DMD patients seldom live beyond 30 years of age. • Wheelchair bound by 8-11 years of age • Severe pulmonary infections are the major cause of mortality along with congestive heart failure secondary to worsening cardiomyopathy.

  16. Board Review Pause • According to the ABA, from the 1995 ITE, more than ½ of CA-3 residents failed to assess cardiac status during preoperative assessment of a 12-year-old patient with Duchenne’s muscular dystophy who is unable to ambulate.

  17. PE Warning Signs • History of motor delay should be explored • Did patient learn to walk with peers • Gait problems/ Falls / Fatigue • Climbing/Descending Stairs • Gower’s sign • Inability to get up from floor without using upper extremities • Enlarged muscles • Family History • Only 10% lack a family history

  18. Calf Hypertrophy Not Specific

  19. Physiologic Changes • Mainly pulmonary and cardiac functions. • Studies have shown that 83% of these patients have ECG abnormalities • Tall R Waves in V1, deep Q waves in limb leads, short PR interval. • Loss of R wave amplitude in lat leads reflects degeneration of myocardial tissue • 26% present heart failure • 31% have chest X-rays changes • 73% have severe pulmonary restriction. • Very often, these patients develop dilated cardiomopathy which may be associated to mitral valve incompetence (papillary muscle dysfunction) (25% of cases). Le Corre F, Plaud B - Neuromuscular disorders. Curr Opin Anesthesiol, 1998;11:333-337

  20. Physiologic Changes • Cardiac arrhythmias and electric conduction defects are also common. • Kyphoscoliosis is another frequent condition, causing pulmonary restriction and very often requiring surgical treatment. • Decreased laryngeal reflexes and prolonged gastric emptying time increase the risk of aspiration and should be considered "full stomach" patients. • Fever, rhabdomyolysis (hyperkalemia, myoglobinuria) and masseter spasm are complications described during anesthetic induction of these patients. • Thought to be at increased risk of MH

  21. Anesthetics Agents and DMD • The FDA banned succinylcholine for DMD patients after the observation of several rhabdomyolysis cases and cardiac arrest by hyperkalemia. • Regional anesthesia could be a good alternative, when possible, for minimally depressing respiratory and cardiovascular systems and requiring minor airway manipulation. • Total intravenous anesthesia may be used, provided care is taken with cardiac depression caused by some agents, and with individual sensitivity to respiratory depression. • Increased sensitivity for nondepolarizing neuromuscular blockers. (Mivacurium probably normal).

  22. History of DMD and Anesthesia • 1994 FDA issued warning against ROUTINE use of succinycholine in infants and children • Succinycholine causes hyperkalemia in DMD • Others have shown succinycholine and VA as cause of cardiac arrest in DMD • Volatile agents have wide and safe use in DMD patients

  23. Recent Developments • Incidence of anesthetic complications • MH is probably not increased • Understanding of AIR • AIR risk changes as disease progresses • Not all volatile agents may be the same • Resuscitation Differs

  24. Incidence of Anes Complications • Breuking E et al, Anaesthetist 2000 • Questionaires to all DMD/BMD families who were treated in a “Muscle Center” from 1983-2000 • 147 DMD families, 53 BMD families with 212 male and 9 female patients

  25. Incidence, cont. • 444 anesthetics • 6 cardiac arrests (asystole) and additional 9 rhabdomyolysis cases • 2 cases without succinylcholine, 2 cases with unknown muscle relaxant • Clear increase in frequency over normal pediatric population

  26. MH vs. AIR • Shift of opinion? • Evidence suggests DMD & MH independent • Malignant Hyperthermia vs. Anesthesia-Induced Rhabdomyolysis • Common Clinical/Biochem Characteristics • hyperkalemia, • metabolic acidosis • myoglobinuria • elevated creatinine kinase

  27. Mechanism of Action of AIR • Anesthetic agents stress a muscle cell membrane that is already ‘fragile’ or ‘unstable’ because of the lack of dystrophin. • Increased membrane permeability results in a compensatory hypermetabolic response in an attempt to re-establish membrane stability and prevent calcium ion fluxes. • Rhabdo involves breakdown of this membrane, resulting in loss of cell contents (myoglobin, K, CK) • VA are likely therefore one factor that must come together to result in rhabdomyolysis Gronert GA, Fowler W, Cardinet GH III, Grix A jr, Ellis WG, Schwartz MZ. Absence of malignant hyperthermia contractures in Becker–Duchenne dystrophy at age 2. Muscle Nerve 1992; 15: 52–6

  28. Timing • A relatively large number of cases occur during recovery from anesthesia • Trigger or precipitating event may simply be movement • Destabilization may occur during high levels of volatile agents intraoperatively • Destablization may occur at very low MAC levels in the PACU • Exceptions

  29. AIR Risk • Different risk for undiagnosed or recently diagnosed DMD patients? • In early phases (less than 8 years of age), unstable muscle fibers attempting to regenerate • These are most prone to rhabdomyolysis • Older, more severely affected children may have more uneventful anesthetics with volatile agents and with succinylcholine. Yemen T: Muscular dystrophy, anesthesia and the safety of inhalational agents revisted, again. Pediatric Anesthesia 2006 16: 105-108

  30. Agent Differences • Sevoflurane may be best • Less potent stimulus for release of calcium from SR • It may be this release of Ca+ that produces muscle membrane damage and AIR • Therefore, less of a trigger in theory Kunst G, Graf BM, Scheiner R et al: Differential effects of sevoflurane, isoflurane, and halothane on Ca2+ release from the sarcoplasmic reticulum of skeletal muscle. Anesthesiology 91:179, 1999

  31. Resuscitation • Different mechanism -> Different outcome • Receptor Upregulation • A presumably finite opening of acetylcholine receptor channels with an intact membrane • Challenge of CPR reduced once K+ channels close • Rhabdomyolysis • Continued loss of K+ from multiple affected muscles secondary to membrane instability • LARGE K+ release may exceed capacity for redistribution Gronert, GA Cardiac Arrest after Succinylcholine: Mortality Greater with Rhabdomyolysis Than Receptor Upregulation. Anesthesiology 2001; 94 (3) 523-526

  32. Cardiac Arrest after Sux Gronert: Anesthesiology; Volume 94 (3). March 2001. 523-529

  33. What’s the Best Answer? • No large prospective trials • TIVA opinion is rapidly gaining in popularity • 24th Pediatric Anesthesia Conference • Toronto, November 2005 • “TIVA should probably be used and anesthetic vapours avoided” Dr. Jason A Hayes, The Hospital for Sick Children, The University of Toronto

  34. Support Groups’ OpinionMDA.org and Parent Project • “General anesthesia is accompanied by a number of important risks. When general anesthesia is required in order to undergo a specific procedure succinylcholine and inhalational anesthetics need to be AVOIDED.” Parent Project, Muscular Dystrophy Website (“By Dr. Margaret Vroom, Anesthesiologist”) http://www.parentprojectmd.org

  35. DMD Summary • DMD has significant anesthetic implications. • Thorough Hx & PE cannot be overstated. • In DMD Rhabdomyolysis is a potential complication not restricted to the use of succinylcholine. • In event of sudden cardiac arrest in apparent healthy child must be alerted to possibility of hyperkalemia and undiagnosed DMD. • In DMD mechanism of hyperkalemia secondary to AIR, not necessarily MH. • Succinycholine should be avoided in DMD. • Perhaps ROUTINE use of VA, especially in younger patients with DMD, should be avoided.

More Related